14.10.2016   

EN

Official Journal of the European Union

C 378/24

1.

On 7 October 2016, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking CGP Peggy SARL (Luxembourg) a special purpose vehicle belonging to the Carlyle Group (‘Carlyle Group’), together with the Schön Family acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of Schön Klink SE (Germany) and its direct and indirect subsidiaries and participations (‘Schön Klinik Group’) by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for Carlyle: is a global alternative asset manager. It manages funds that invest globally across four investment disciplines: (i) corporate private equity, (ii) real assets, (iii) global market strategies and (iv) investment solutions.

—   for Schön Klinik Group: private hospital operator for publicly and privately insured patients in Germany which focuses on the acute medical segments mental illnesses, orthopaedics and neurology.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference M.8146 — Carlyle/Schön Klinik, to the following address: